Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2025-12-28 @ 9:03 PM
Study NCT ID:
NCT04835168
Status:
WITHDRAWN
Last Update Posted:
2023-06-07
First Post:
2021-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
Sponsor:
NImmune Biopharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-10
First Submit QC Date:
None
Study First Post Date:
2021-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-06
Last Update Post Date:
2023-06-07
Last Update Post Date Type:
ACTUAL